Vertex Pharmaceuticals - Boston, MA
posted 2 months ago
Vertex Pharmaceuticals is seeking a Director, Clinical Trial Liaison to enhance the Clinical Research site experience by prioritizing customer engagement. This strategic role serves as a vital link between Vertex and Clinical Research sites, focusing on therapeutic area networking, site outreach, education, specialized training, and accelerating patient enrollment. The Director will report to the Senior Director of GCO, Patient and Site Engagement, and must possess a deep understanding of clinical research and regulatory requirements. The role involves leading the Site Engagement team and requires expertise in multiple therapeutic areas. In this position, the Director will represent Vertex in direct interactions with clinical trial investigators and academic institutions, particularly during the feasibility stage of studies. Responsibilities include conducting routine visits, identifying new sites for consideration, and conducting outreach within therapeutic areas. The Director will also identify opportunities for process improvements to enhance study execution and provide feedback to the function and study team. As a key decision-maker in country and site selection activities, the Director will collaborate with Medical Affairs to represent regional insights and interests. The role requires anticipating and escalating site-specific challenges, supporting trial and protocol design, and conducting targeted investigator interviews. The Director will also be responsible for training site personnel on the investigational product and study design, as well as accelerating patient enrollment through referrals and awareness initiatives. Additionally, the Director will define, monitor, and report Key Performance Indicators (KPIs) for site performance, stay updated on regulations and industry trends, and manage a global team, including the assignment of Disease Area Leads. The position demands a proactive approach to maintaining compliance and ensuring streamlined site start-up processes.